Owen Gareth, Keshava Anil, Stewart Peter, Patterson James, Chapuis Pierre, Bokey Elie, Rickard Matthew
Department of Colorectal Surgery, Concord Repatriation General Hospital, Hospital Road, Concord, NSW 2139, Australia.
ANZ J Surg. 2010 May;80(5):341-3. doi: 10.1111/j.1445-2197.2010.05278.x.
The purpose of this study was to analyse preliminary experience and outcomes with the Cook Surgisis AFP anal fistula plug (Cook Medical, Bloomington, IN, USA) with respect to the treatment of complex anal fistulae in a specialist colorectal unit.
Data on all patients who were treated with the Surgisis AFP between October 2006 and January 2009 were retrospectively reviewed. The plug was placed in accordance with the Cook guidelines. Successful closure of the anal fistula was defined as absence of drainage at final follow-up with no subsequent abscess formation or further intervention required.
Thirty-two patients underwent a total of 35 anal fistula plug insertion procedures. No patients were lost to follow-up. The median follow-up was 15 months (2-29 months). The overall success rate was 13 out of 35 (37%). For those in the subgroups of Crohn's disease and cryptoglandular disease, the success rate was 1 out of 3 (33%) and 11 out of 31 (35%), respectively.
This series demonstrates a success rate for the Cook Surgisis AFP of 37%. These results in patients managed in a specialist unit confirm that the Surgisis AFP is a useful option in the management of complex fistulae.
本研究旨在分析美国印第安纳州布鲁明顿市库克医疗公司生产的库克 Surgisis AFP 肛瘘栓在专科结直肠病治疗中心治疗复杂性肛瘘的初步经验和疗效。
回顾性分析 2006 年 10 月至 2009 年 1 月期间所有接受 Surgisis AFP 治疗的患者的数据。肛瘘栓的放置按照库克公司的指南进行。肛瘘成功闭合的定义为末次随访时无引流,且无后续脓肿形成或无需进一步干预。
32 例患者共接受了 35 次肛瘘栓置入手术。无患者失访。中位随访时间为 15 个月(2 - 29 个月)。总体成功率为 35 例中的 13 例(37%)。在克罗恩病和隐窝腺病亚组中,成功率分别为 3 例中的 1 例(33%)和 31 例中的 11 例(35%)。
本系列研究表明库克 Surgisis AFP 的成功率为 37%。在专科治疗中心对患者的这些结果证实,Surgisis AFP 是治疗复杂性肛瘘的一种有用选择。